Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301) for tetanus

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Apr 2014: Trial registered, NCT02118961

The trials

NCT02118961: Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents

State
Completed
Phase
Phase 3
People
446 taking part
Started
Apr 2014
Primary completion
Aug 2014
Arms
BK1301
Results
Posted on the registry
  1. 21 Apr 2014: Trial registered
  2. 21 Nov 2016: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.